257 related articles for article (PubMed ID: 18460247)
1. Gastric corpus polyps associated with Proton Pump Inhibitors therapy.
Yakoob J; Abbas Z; Jafri W; Ahmad Z
J Coll Physicians Surg Pak; 2008 Mar; 18(3):172-3. PubMed ID: 18460247
[TBL] [Abstract][Full Text] [Related]
2. Proton-pump inhibitor-induced fundic gland polyps with hematemesis.
Tanaka M; Kataoka H; Yagi T
Clin J Gastroenterol; 2019 Apr; 12(2):193-195. PubMed ID: 30251013
[TBL] [Abstract][Full Text] [Related]
3. Gastric fundic gland polyps: a clinico-pathological study from North West Tasmania.
Samarasam I; Roberts-Thomson J; Brockwell D
ANZ J Surg; 2009 Jun; 79(6):467-70. PubMed ID: 19566871
[TBL] [Abstract][Full Text] [Related]
4. Fundic gland polyps are not induced by proton pump inhibitor therapy.
Vieth M; Stolte M
Am J Clin Pathol; 2001 Nov; 116(5):716-20. PubMed ID: 11710689
[TBL] [Abstract][Full Text] [Related]
5. Sporadic fundic gland polyps are not associated with proton pump inhibitors therapy but negatively correlate with Helicobacter pylori infection in China.
Cao H; Qu R; Zhang Z; Kong X; Wang S; Jiang K; Wang B
Chin Med J (Engl); 2014; 127(7):1239-43. PubMed ID: 24709173
[TBL] [Abstract][Full Text] [Related]
6. Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection.
Miyamoto S; Kato M; Matsuda K; Abiko S; Tsuda M; Mizushima T; Yamamoto K; Ono S; Kudo T; Shimizu Y; Hatanaka KC; Tsunematsu I; Sakamoto N
Intern Med; 2017; 56(14):1825-1829. PubMed ID: 28717077
[TBL] [Abstract][Full Text] [Related]
7. Relative risk factors associated with the development of fundic gland polyps.
Huang CZ; Lai RX; Mai L; Zhou HL; Chen HJ; Guo HX
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1217-21. PubMed ID: 25187299
[TBL] [Abstract][Full Text] [Related]
8. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
Raghunath AS; Hungin AP; Mason J; Jackson W
Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
[TBL] [Abstract][Full Text] [Related]
9. Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration.
Takeda T; Asaoka D; Tajima Y; Matsumoto K; Takeda N; Hiromoto T; Okubo S; Saito H; Aoyama T; Shibuya T; Sakamoto N; Hojo M; Osada T; Nagahara A; Yao T; Watanabe S
Clin J Gastroenterol; 2017 Oct; 10(5):478-484. PubMed ID: 28660530
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of proton pump inhibitors.
Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G
Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):193-201. PubMed ID: 20227032
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients.
Reimer C; Bytzer P
Aliment Pharmacol Ther; 2009 Oct; 30(7):725-32. PubMed ID: 19604180
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy.
Jalving M; Koornstra JJ; Wesseling J; Boezen HM; DE Jong S; Kleibeuker JH
Aliment Pharmacol Ther; 2006 Nov; 24(9):1341-8. PubMed ID: 17059515
[TBL] [Abstract][Full Text] [Related]
14. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
Beaumont H; Boeckxstaens GE
Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
[TBL] [Abstract][Full Text] [Related]
15. Is there a dark side to long-term proton pump inhibitor therapy?
Nealis TB; Howden CW
Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
[TBL] [Abstract][Full Text] [Related]
16. Fundic gland polyps: a still elusive entity on the eve of the year 2000.
Declich P; Ambrosiani L; Grassini R; Tavani E; Bellone S; Bortoli A; Gozzini C; Prada A
Pol J Pathol; 2000; 51(1):3-8. PubMed ID: 10833897
[TBL] [Abstract][Full Text] [Related]
17. [Gastric polyposis due to treatment with proton pump inhibitors].
Huguet JM; Ruiz L; Ortí E; Luján M; Sempere J; Medina E
Gastroenterol Hepatol; 2009 Feb; 32(2):88-91. PubMed ID: 19231680
[TBL] [Abstract][Full Text] [Related]
18. The changing histological pattern of gastric polyps in an ethnically heterogeneous population.
Peretz A; Fuchs T; Livovsky DM; Turvall E; Pappo O; Ackerman Z
Scand J Gastroenterol; 2012 Sep; 47(8-9):907-13. PubMed ID: 22577830
[TBL] [Abstract][Full Text] [Related]
19. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients.
Carmack SW; Genta RM; Schuler CM; Saboorian MH
Am J Gastroenterol; 2009 Jun; 104(6):1524-32. PubMed ID: 19491866
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
